
Andrea Cox
@andreacoxmdphd
Viral immunologist dedicated to vaccine development. Infectious disease specialist and passionate advocate for physician scientists in training.
ID: 1321805709500129280
29-10-2020 13:27:04
33 Tweet
385 Takipçi
213 Takip Edilen




Excited to create this podcast with Consultant360 on HCV- which caused more deaths than all the other reportable infectious diseases combined from 2011 until COVID19. Half of infected Americans don’t know they have HCV. Test everyone/get tested, please. podcasts.apple.com/us/podcast/and…


Got a great Yeti tumbler from AUM BioTech while learning about RNA silencing FANA ASO technology. Planning to try this in primary macrophages #AAI2022 #Immunology2022


apple.news/A8oKHDhLpTZWz5… We study sex differences in inflammation and the impact on diverse diseases. Gordon Research Conferences on sex differences in immunity addresses how inflammatory diseases affect women differently. Register! grc.org/sex-difference… NIH Women's Health FDAWomen

Excited to share that our paper on MIS-C pathogenesis is coming soon! Journal of Infectious Diseases #COVIDresearch Andrea Cox


ID in the News: @CMDurandMD discusses the road from the #HIV epidemic of the 1990s to life-changing HIV-HIV donor transplant, pioneered Johns Hopkins Medicine Changing the Rules: HIV Positive & Donating Organs walb.com/2024/04/15/cha…

New Johns Hopkins Medicine Johns Hopkins Division of Infectious Diseases paper (bit.ly/4aVPOAn) & blog (bit.ly/3W1wjCd) describe how #COVID19 #vaccines induce different immune responses in children who have solid organ transplants compared to their siblings. Katerina Roznik Andrea Cox Johns Hopkins Bloomberg School of Public Health



Review paper in Science Translational Medicine (bit.ly/3CwCeaY) by Johns Hopkins Medicine Johns Hopkins Division of Infectious Diseases #AnnieAntarMDPhD & Andrea Cox chronicles progress of studies to understand mechanisms & epidemiology of #LongCOVID, as well as clinical trials trying to translate that insight into therapies.


In a new Review, researchers parse emerging insights into the mechanisms of #LongCovid, obstacles and opportunities in clinical translation, and the latest results from the first clinical trials of promising therapeutics. Andrea Cox Johns Hopkins Medicine bit.ly/3CwybLO



ID in the News: Important findings on #RSV vaccine efficacy among people who are immunocompromised from Andrew Karaba & William Werbel MD PhD

Morning Read: Medicine for a Changing Planet: Online Clinical Cases in Planetary Health and Infectious Diseases: Seth Judson, MD, MHS and colleagues academic.oup.com/ofid/article/d…

New study in Science Translational Medicine (bit.ly/3YUnScG) by Johns Hopkins Medicine Johns Hopkins Bloomberg School of Public Health Andrew Pekosz Andrew Karaba Eileen Scully Johns Hopkins Division of Infectious Diseases So excited that our research is out in STM and hope it helps improve treatment of severe COVID-19!